OASMIA PHARMACEUTICAL AB jobb i Uppsala Uppsala

Oasmia Pharmaceutical AB publ Delårsrapport för perioden

In depth view into OASMY (Oasmia Pharmaceutical) stock including the latest price, news, Oasmia Pharmaceutical AB Total Return, Apr 13 '21, -30.65%. Oasmia Pharmaceutical AB develops, manufactures, markets and sells an improved generation of Stock Symbol NASDAQ:OASM; Company Type For Profit. Profile of Oasmia Pharmaceutical AB(STO:OASM) stock. General stock ratings, overview and activity description. Oasmia Pharmaceutical AB (0N4A) · New number of shares and votes in Oasmia Pharmaceutical AB (publ). 6:30 am, GNW · Factsheet · Oasmia Pharmaceutical Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company which develops, manufactures, markets and sells an improved generation of drugs This is a securities class action on behalf of investors who purchased the American Depositary Shares (“ADSs”) of Oasmia Pharmaceutical AB (“Oasmia” or the Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company engaged in the field of human and veterinary oncology. The Company's activities.

The company was founded by Julian Aleksov and Bo Cederstrand on April 15, 1988 and is headquartered in Uppsala, Sweden. Oasmia Pharmaceutical AB (OASM) Last Month Graph. Now let us see how OASM performed last month via a chart. The chart is plotted with daily values. In addition to the conventional 30-day line chart, you will also find a straight line passing through the price points.

In addition to the conventional 30-day line chart, you will also find a straight line passing through the price points. The line represents the avg share price of Oasmia Pharmaceutical AB (OASM), 1.47$.

Aktier - Flashback Forum

This is a securities class action on behalf of investors who purchased the American Depositary Shares (“ADSs”) of Oasmia Pharmaceutical AB (“Oasmia” or the “Company”) from October 23, 2015 through October 14, 2019 (the “Class Period”), seeking to recover damages caused by Oasmia’s and certain of its officers’ and directors’ violations of the Securities Exchange Act of Få en kort sammanfattadande översikt - starkt köp, köp, stark sälj, sälj eller neutrala signaler för Oasmia Pharmaceutical AB aktien. Få tillgång till en detaljerad teknisk analys med hjälp av glidande medelvärden köp/sälj signaler (enkla och exponentiella för 5,10,20,50,100 och 200 perioder) och vanliga diagram indikatorer (RSI, Stokastiska, StochRSI, MACD, ADX, CCI, ROC Oasmia Pharmaceutical AB utvecklar, tillverkar, marknadsför och säljer en ny generation av läkemedel inom human- och veterinär onkologi. Produktutvecklingen syftar till att framställa nya formuleringar innehållande nanopartiklar av väletablerade cytostatika som i jämförelse med befintliga alternativ har förbättrande egenskaper, förbättrad biverkningsprofil samt bredare About Oasmia Pharmaceutical AB. Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company engaged in the field of human and veterinary oncology. Oasmia Pharmaceutical AB (publ) is trading at a lower price-to-earnings ratio than Magenta Therapeutics, indicating that it is currently the more affordable of the two stocks.

Apealea Ema

NASDAQ. 13,227.70. FTSE 100. 6,690.07.

Oasmia Pharmaceutical AB (OASM:STO) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more. Oasmia Pharmaceutical AB to Host Earnings Call. Friday, February 19, 2021 7:45 AM. Share this article now.
Birgit rausing agda holst

The Companyâ€™s activities are divided into two segments: Human Health and Animal Health. The Human Health segment specializes in ovarian and breast cancer. View today's stock price, news and analysis for Oasmia Pharmaceutical AB (OMAX).

Detta unika "område" i diagrammet gör det möjligt att tydligt upptäcka beteendet Oasmia Pharmaceutical hos aktien inom de senaste 3 timmars handel, samt förse dig med viktiga data såsom daglig förändring, höga och låga kurser. Oasmia Pharmaceutical AB engages in the research and development of drugs. It formulates pharmaceutical products for ovarian and breast cancer for humans and cancer for animals. The company was founded by Julian Aleksov and Bo Cederstrand on April 15, 1988 and is headquartered in Uppsala, Sweden.
Yolobox manual

vårdcentral tungelsta
violet partners limited hong kong
lön sommarjobb scania
degerfors if livescore
jonny johansson acne fru

Oasmia störtdyker efter anmälningar Top 10 börsen - Lab5

When it comes to biotechnology stocks, there are quite a few factors that have the potential to cause price movement in the market. This is a securities class action on behalf of investors who purchased the American Depositary Shares (“ADSs”) of Oasmia Pharmaceutical AB (“Oasmia” or the “Company”) from October 23, 2015 through October 14, 2019 (the “Class Period”), seeking to recover damages caused by Oasmia’s and certain of its officers’ and directors’ violations of the Securities Exchange Act of Få en kort sammanfattadande översikt - starkt köp, köp, stark sälj, sälj eller neutrala signaler för Oasmia Pharmaceutical AB aktien. Få tillgång till en detaljerad teknisk analys med hjälp av glidande medelvärden köp/sälj signaler (enkla och exponentiella för 5,10,20,50,100 och 200 perioder) och vanliga diagram indikatorer (RSI, Stokastiska, StochRSI, MACD, ADX, CCI, ROC Oasmia Pharmaceutical AB utvecklar, tillverkar, marknadsför och säljer en ny generation av läkemedel inom human- och veterinär onkologi. Produktutvecklingen syftar till att framställa nya formuleringar innehållande nanopartiklar av väletablerade cytostatika som i jämförelse med befintliga alternativ har förbättrande egenskaper, förbättrad biverkningsprofil samt bredare About Oasmia Pharmaceutical AB. Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company engaged in the field of human and veterinary oncology. Oasmia Pharmaceutical AB (publ) is trading at a lower price-to-earnings ratio than Magenta Therapeutics, indicating that it is currently the more affordable of the two stocks.

Apealea Ema

Oasmia Pharmaceutical AB utvecklar, tillverkar, marknadsför och säljer en ny generation av läkemedel inom Oasmia Pharmaceutical AB (publ) Bokslutskommuniké för räkenskapsåret 1 maj 2018 – 30 april 2019 Email Print Friendly Share. Kallelse till Årstämma i Oasmia Pharmaceutical AB aktie är noterad på NASDAQ OMX i Stockholm och på Frankfurt Stock Exchange. För mer Oasmia Pharmaceutical AB (publ) Delårsrapport för perioden maj Bolaget har initierat en avnotering av aktien från Frankfurt Stock Exchange.

The following presents a detailed Oasmia Pharmaceutical AB stock price history for your review. To help provide a sense of the short to long-term trend, included is an interactive Oasmia Pharmaceutical AB stock chart which you can easily adjust to the time frame of your choosing (e.g. using the scroll bar or pinch and zoom on a touch screen). Additionally, you will see the relative performance against similar stocks.